Diabetic nephropathy, which represents a major form of chronic kidney disease (CKD), is a
leading cause of end-stage renal disease worldwide, and is also a risk factor for …

Background and Objectives: The recent SHARP trial clearly demonstrated that a reduction in
low-density lipoprotein (LDL) cholesterol with a daily regimen of simvastatin plus ezetimibe …

Significance: The relationship between lipid disturbances and renal diseases has been
studied for several decades, and it is well recognized that when the balance of renal lipid …

Chronic kidney disease (CKD) presents a substantial global public health challenge, with
high morbidity and mortality. CKD patients often experience dyslipidaemia and poor …

The decline of the estimated glomerular filtration rate (eGFR) and the presence of
albuminuria are the typical hallmarks of kidney disease arising as one of the most frequent …

There is accumulating evidence that advanced glycation end products (AGEs) play a role in
the development and progression of chronic kidney disease (CKD). We have previously …

Background Urinary bladder and renal dysfunction are secondary events associated with
spinal cord injury (SCI) in humans. These secondary events not only compromise quality of …

Hydrogen sulfide (H 2 S) is a crucial co-modulator of cardiovascular, nervous, digestive and
excretory systems function. The pleio-tropic action of atorvastatin exceeds simple 3-hydroxy …

Acute renal failure is a serious condition of Crotalus bites, which could be treated with
statins. The effects of Crotalus durissus terrificus venom (vCdt) and simvastatin on renal …

Background/aims Nephrotic dyslipidemia is a risk factor for the development of systemic
atherosclerosis; it may also aggravate glomerulosclerosis and enhance the progression of …